Trial intelligence / Profile preview

Dexmedetomidine added to spinal anesthesia versus adductor canal block for knee surgery

PACTR202507698362506Phase 3Completed

Sponsor
Suez Canal University
Start
Jun 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine (2 arms), sponsored by Suez Canal University. Primary endpoint: Time to first request of analgesia. Started Jun 2025; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on PACTR202507698362506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202507698362506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call